US Patent Issued to H. Lee Moffit Cancer Center and Research Institute on Dec. 9 for "Use of MCT1 inhibitors to enhance insulin sensitivity" (Florida Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,491,187, issued on Dec. 9, was assigned to H. Lee Moffit Cancer Center and Research Institute Inc. (Tampa, Fla.).

"Use of MCT1 inhibitors to enhance insulin sensitivity" was invented by Patricia McDonald (Land O Lakes, Fla.) and Tracey Bailey (Tampa, Fla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein is a method for promoting insulin sensitivity in a subject that involves administering to the subject a therapeutically effective amount of a composition comprising an monocarboxylate transporter 1 (MCT1) inhibitor. For example, the subject can have or be at risk of developing a metabolic disorder characterized by high blood glucose and low...